Omar Ragy

525 total citations
9 papers, 34 citations indexed

About

Omar Ragy is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Omar Ragy has authored 9 papers receiving a total of 34 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Nephrology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Omar Ragy's work include Renal Diseases and Glomerulopathies (7 papers), Vasculitis and related conditions (5 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers). Omar Ragy is often cited by papers focused on Renal Diseases and Glomerulopathies (7 papers), Vasculitis and related conditions (5 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers). Omar Ragy collaborates with scholars based in United Kingdom, Mexico and Spain. Omar Ragy's co-authors include Durga Kanigicherla, Patrick Hamilton, Jecko Thachil, Arif Khwaja, Alison Smith, Anirudh Rao, Paul Brenchley, Sandip Mitra, Katherine H. Parker and Janine Bestall and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Nephrology Dialysis Transplantation.

In The Last Decade

Omar Ragy

7 papers receiving 32 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Omar Ragy United Kingdom	3	29	17	5	5	4	9	34
Catalina Martín Cleary Spain	1	22 0.8×	5 0.3×	7 1.4×	5 1.0×	10 2.5×	2	42
Zoé A. Kibbelaar United States	2	35 1.2×	17 1.0×	2 0.4×		3 0.8×	3	42
Janette Cansick United Kingdom	5	48 1.7×	24 1.4×	10 2.0×		14 3.5×	6	69
Rocco Baccaro Italy	4	9 0.3×	11 0.6×	7 1.4×		6 1.5×	8	33
Shu Cheng Chen Hong Kong	2	20 0.7×	4 0.2×	5 1.0×		4 1.0×	7	34
Rey Isidto Netherlands	2	16 0.6×	9 0.5×	4 0.8×		8 2.0×	4	51
Levent Korkmaz Türkiye	4	19 0.7×	5 0.3×	14 2.8×		5 1.3×	5	35
Irene Agraz Pamplona Spain	3	33 1.1×	14 0.8×	1 0.2×		5 1.3×	7	34
Külli Kõlvald Estonia	3	21 0.7×	5 0.3×			2 0.5×	3	30
Daniela Lopes Portugal	4	12 0.4×	4 0.2×	9 1.8×		5 1.3×	13	34

Countries citing papers authored by Omar Ragy

Since Specialization

Citations

This map shows the geographic impact of Omar Ragy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omar Ragy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omar Ragy more than expected).

Fields of papers citing papers by Omar Ragy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Omar Ragy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omar Ragy. The network helps show where Omar Ragy may publish in the future.

Co-authorship network of co-authors of Omar Ragy

This figure shows the co-authorship network connecting the top 25 collaborators of Omar Ragy. A scholar is included among the top collaborators of Omar Ragy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Omar Ragy. Omar Ragy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Ragy, Omar, Durga Kanigicherla, Bethany Shinkins, et al.. (2025). PLA2R autoantibodies, a multifaceted biomarker in nephrotic syndrome and membranous nephropathy. Nephrology Dialysis Transplantation. 40(8). 1458–1469. 1 indexed citations

2.

Ragy, Omar, et al.. (2025). Use of rituximab and plasma exchange in treatment and prophylaxis of recurrent FSGS. Clinical Kidney Journal. 18(3). sfaf058–sfaf058. 1 indexed citations

3.

Hamilton, Patrick, et al.. (2025). Impact of Time-To-Treatment on Outcomes in Autoimmune Membranous Nephropathy. Kidney International Reports. 10(6). 1907–1916. 1 indexed citations

4.

Ragy, Omar, et al.. (2023). Can use of the serum anti-PLA2R antibody negate the need for a renal biopsy in primary membranous nephropathy?. PLoS ONE. 18(2). e0281726–e0281726. 8 indexed citations

5.

McDonnell, Thomas, et al.. (2023). Longitudinal Analysis of Prophylactic Anticoagulation in Primary Nephrotic Syndrome: Low Incidence of Thromboembolic Complications. SHILAP Revista de lepidopterología. 3(1). 266–274.

6.

Ragy, Omar, et al.. (2023). Thromboembolism in nephrotic syndrome: controversies and uncertainties. Research and Practice in Thrombosis and Haemostasis. 7(6). 102162–102162. 15 indexed citations

7.

Ragy, Omar, et al.. (2023). Long-Term Safety, Clinical and Immunological Outcomes in Primary Membranous Nephropathy with Severe Renal Impairment Treated with Cyclophosphamide and Steroid-Based Regimen. SHILAP Revista de lepidopterología. 3(1). 88–97. 2 indexed citations

8.

Ragy, Omar, et al.. (2023). PLA2R Antibody Does Not Outperform Conventional Clinical Markers in Predicting Outcomes in Membranous Nephropathy. Kidney International Reports. 8(8). 1605–1615. 6 indexed citations

9.

Herbert, Rob, et al.. (2020). SAT-050 OUT OF THE FRYING PAN INTO THE FIRE: 2 CASE REPORTS OF PROGRESSIVE RENAL FAILURE SECONDARY TO PEMETREXED. Kidney International Reports. 5(3). S22–S22.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact